ARJO B Share Price Performance
SEK 0
-32.08 (-100.00%)
Price SEK 0
Fair ValueSEK 34.00
Share Pricen/a
Arjo AB (publ) Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 18 Fair Values set on narratives written by author
ARJO B Community Narratives
AN
Fair Value SEK 34 21.4% undervalued intrinsic discount
Connected Care And Aging Trends Will Drive New Global Demand
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value SEK 28 4.5% undervalued intrinsic discount
Cutting Reimbursements And Home Care Shift Will Erode Demand
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value SEK 29.75 10.1% undervalued intrinsic discount
Leadership Changes And Evolving Market Dynamics Will Shape Future Opportunity
0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
Leadership Changes And Evolving Market Dynamics Will Shape Future Opportunity
Key Takeaways Expansion in Patient Handling, rental, and new markets supports revenue growth and reduces reliance on mature regions. Demographic shifts and cost efficiency measures strengthen stable, recurring earnings and improve margins.Read more
61
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
AN
SEK 29.75
10.1% undervalued intrinsic discount
Fair Value
Revenue
2.65% p.a.
Profit Margin
5.95%
Future PE
14.24x
Price in 2029
SEK 36.98
Connected Care And Aging Trends Will Drive New Global Demand
Key Takeaways Robust order growth, transformative product launches, and strategic global expansion position Arjo for sustained revenue outperformance and higher gross margins. Structural healthcare trends and disciplined cost controls support long-term demand, improved profitability, and resilience against market and macroeconomic risks.Read more
13
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
SEK 34
21.4% undervalued intrinsic discount
Fair Value
Revenue
2.71% p.a.
Profit Margin
6.66%
Future PE
14.49x
Price in 2029
SEK 42.2
Cutting Reimbursements And Home Care Shift Will Erode Demand
Key Takeaways Reliance on facility-based solutions and mature markets exposes Arjo to pricing pressure, limited growth, and margin compression amid shifting care models and economic constraints. Slow adaptation to digital health innovations and mounting competitive threats risk product obsolescence, market share loss, and persistent profitability challenges.Read more
7
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
SEK 28
4.5% undervalued intrinsic discount
Fair Value
Revenue
1.41% p.a.
Profit Margin
5.51%
Future PE
14.96x
Price in 2029
SEK 34.75
Trending Discussion
Recently Updated Narratives
AN
ARJO B: Revised Assumptions Suggest Fair Value With Moderate Longer Term Upside Potential
Fair Value: SEK 29.75 10.1% undervalued intrinsic discount
8 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
ARJO B: Improved Margins And Lower Risk Profile Will Support Future Upside
Fair Value: SEK 34 21.4% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
ARJO B: Future Returns Will Rely On Stable Margins And Required Yield
Fair Value: SEK 28 4.5% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Arjo AB (publ) Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Jul 14, 2026
- 1.23
- 42.59%
- 3.04%
- 55.3%
About ARJO B
- Founded
- 1957
- Employees
- 7000
- CEO
- WebsiteView website
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, hygiene, prevention of pressure injuries and blood clots, and leg ulcer treatment and prevention, as well as for obstetric and cardiac diagnostics. The company also provides dementia care, bariatric room solutions, prone positioning, early mobility, architects and planners, and rehabilitation services, as well as equipment repair and maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. Arjo AB (publ) was founded in 1957 and is headquartered in Malmö, Sweden.
